B · Normal
[The concept of innovative drugs continues to weaken, and InnoCare falls more than 10%] On September 24th, the concept of innovative drugs continued to weaken. InnoCare once shot up and turned red in the afternoon and then quickly fell back. It is now down more than 10%. Previously, Harbin Pharmaceutical Co., Ltd. fell by the limit, and Chengda Pharmaceutical, Medicilon, Bepsis, Ellis, Enos, Kelun Pharmaceutical and other stocks fell more than 6%.
Live broadcast 🕐 2026-09-24 14:13
#Live broadcast #Innovative drugs #Medici
Save as Image Generate a beautiful long image to share on Moments or in group chats Generate now ⬇
← Back to Telegraph

Related telegraphs

[Analysis of daily limit on September 24] On September 24, a total of 52 stocks 09-24 15:10 [Review: The ChiNext Index and Shenzhen Component Index opened lower and moved l 09-24 15:01 [The transaction volume of the Shanghai and Shenzhen stock markets exceeded 1.5 09-24 14:43 [Partial changes in Fujian local stocks, Strait Innovation and Pingtan Developme 09-24 14:24 [Main Fund Monitoring: Zhongji InnoLight’s net sales exceeded 1.3 billion] On Se 09-24 14:20 [Near-end sub-new concepts continue to fall. Century Digital has fallen by 30cm 09-24 14:16

Comments

0/500
Captcha (click to refresh)
No comments yet